Box score
Interius BioTherapeutics, Inc.
Reported $51.4M sold in a new Form D filed June 3, 2024 (Philadelphia, Pennsylvania).
- Biggest raise
- $51.4M filed Jun 3, 2024
- League
- Bio & Health Biotechnology
- Based in
- Philadelphia, Pennsylvania
- Season rank
- #96 of 1,389 in the Bio & Health League; #374 of 12,443 overall (2024)
- Incorporated
- 2019
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-06-03 | New notice | $51.4M | $82.5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1807811.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Aclaris Therapeutics, Inc. | Bio & Health | $80M |
| 2 | Third Arc Bio, Inc. rookie | Bio & Health | $72.5M |
| 3 | Cagent Vascular, Inc. | Bio & Health | $28.7M |
| 4 | PeopleOne Health, Inc. | Bio & Health | $23.7M |
| 5 | Reunion Neuroscience Management, Inc. rookie | Bio & Health | $16.9M |
| 6 | Novasenta Inc. | Bio & Health | $15M |